Galectin Therap (GALT.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec18

Fund L.P. 10X Sells Galectin Therapeutics Shares

16:44

Dec5

Galectin Therapeutics Inc. Releases New Data on Galectin-3 Inhibitor Belapectin

21:15

Nov15

Galectin Therap released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.128 (forecast USD -0.11)

04:00

Galectin Therap released FY2025 9 Months earnings on November 14 (EST), actual revenue USD 0, actual EPS USD -0.4015

04:00

Nov10

Galectin Therapeutics Reports Positive Results for Belapectin in MASH Liver Disease 2b Phase NAVIGATE Trial

12:57

Aug15

Galectin Therap released FY2025 Semi-Annual earnings on August 14 (EST), actual revenue USD 0, actual EPS USD -0.2714

03:00

Schedules & Filings

Schedules

Filings

Nov14

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -8.223 M, EPS -0.128

Aug14

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -7.584 M, EPS -0.1195

May15

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -9.605 M, EPS -0.1519

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change